drugset / Trial / NCT01282138

Assessment of Alcon's Ocular Image Quantification System

NCT01282138

Phase 4 Completed 13 enrolled Alcon Research
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study was to evaluate ocular responses with different allergen provocation methods.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified 0.1 % Topical

Indications